# First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants

> **NCT03919409** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical R&D Inc.** · enrollment: 70 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TS-161
- **DRUG:** TS-161 Placebo

## Key facts

- **NCT ID:** NCT03919409
- **Lead sponsor:** Taisho Pharmaceutical R&D Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-03
- **Primary completion:** 2020-02-11
- **Final completion:** 2020-02-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2020-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03919409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03919409, "First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03919409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*